Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors

被引:0
|
作者
Jaremtchuk, AV
Zarba, JJ
Ferro, A
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
662
引用
收藏
页码:138 / 139
页数:2
相关论文
共 50 条
  • [1] A phase I study of gemcitabine and docetaxel for advanced stage solid tumors
    Poole, ME
    Bernard, SA
    Churchel, MA
    Weissler, MC
    Calvo, B
    Cance, W
    Ollila, D
    Koruda, M
    Behrns, K
    Detterbeck, FC
    [J]. CANCER INVESTIGATION, 2003, 21 (03) : 350 - 354
  • [2] A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors
    Ryan, DP
    Lynch, TJ
    Grossbard, ML
    Seiden, MV
    Fuchs, CS
    Grenon, N
    Baccala, P
    Berg, D
    Finkelstein, D
    Mayer, RJ
    Clark, JW
    [J]. CANCER, 2000, 88 (01) : 180 - 185
  • [3] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [4] Phase I study of docetaxel and ifosfamide in patients with advanced solid tumors
    Pronk, L
    Shrijvers, D
    LocciTonelli, D
    Verweij, J
    VanOosterom, AT
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 961 - 961
  • [5] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
  • [6] Phase I clinical and pharmacologic study of docetaxel and gemcitabine in patients with advanced solid tumors; a novel two week schedule
    Obrocea, M
    Davis, TH
    Lewis, LD
    Maurer, LH
    Pipas, JM
    Smith, EL
    Meyer, LP
    Hammond, S
    Rigas, JR
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 95 - 95
  • [7] Phase I and pharmacokinetic study of docetaxel and irinotecan in patients with advanced solid tumors
    Couteau, C
    Risse, ML
    Ducreux, M
    Lefresne-Soulas, F
    Riva, A
    Lebecq, A
    Ruffié, P
    Rougier, P
    Lokiec, F
    Bruno, R
    Armand, JP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3545 - 3552
  • [8] Docetaxel and ifosfamide in patients with advanced solid tumors: Results of a phase I study
    Pronk, LC
    Schrijvers, D
    Schellens, JHM
    de Bruijn, EA
    Planting, AST
    Locci-Tonelli, D
    Groult, V
    Verweij, J
    van Oosterom, AT
    [J]. SEMINARS IN ONCOLOGY, 1998, 25 (01) : 23 - 28
  • [9] Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors
    Pronk, LC
    Schellens, JHM
    Planting, AST
    vandenBent, MJ
    Hilkens, PHE
    vanderBurg, MEL
    deBoerDennert, M
    Ma, J
    Blanc, C
    Harteveld, M
    Bruno, R
    Stoter, G
    Verweij, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1071 - 1079
  • [10] A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors
    Witta, SE
    Gustafson, DL
    Pierson, AS
    Menter, A
    Holden, SN
    Basche, M
    Persky, M
    O'Bryant, CL
    Zeng, C
    Baron, A
    Long, ME
    Gibbs, A
    Kelly, K
    Bunn, PA
    Chan, DC
    Pallansch, P
    Eckhardt, SG
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7229 - 7237